StockNews.com Initiates Coverage on ObsEva (NASDAQ:OBSV)

Investment analysts at StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a report issued on Monday. The brokerage set a “hold” rating on the stock.

ObsEva Stock Down 15.5 %

Shares of OBSV stock opened at $0.10 on Monday. ObsEva has a 12-month low of $0.08 and a 12-month high of $2.14. The company has a fifty day moving average price of $0.01. The firm has a market cap of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.